Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling.
Ruyi ZhangShanshan LiKelly SchippersYunlong LiBoaz EimersMarla LavrijsenLing WangGuofei CuiXin ChenMaikel Petrus PeppelenboschJoyce H G LebbinkRon SmitsPublished in: Cancer research (2024)
Characterization of 80 tumor-associated missense variants of AXIN1 reveals a subset of 18 mutations that disrupt its β-catenin regulatory function, whereas the majority are passenger mutations.